ImmunoGen
IMGN
#1885
Rank
A$13.08 B
Marketcap
$46.84
Share price
0.00%
Change (1 day)
126.65%
Change (1 year)

Market capitalization of ImmunoGen (IMGN)

Last known market cap: A$13.08 Billion

On April 12, 2024 ImmunoGen had a market cap of A$13.08 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ImmunoGen from 2001 to 2024

End of year Market Cap

Year Market cap Change
2024A$13.08 B12.33%
2023A$11.64 B623.97%
2022A$1.60 B-28.37%
2021A$2.24 B37.82%
2020A$1.62 B49.48%
2019A$1.09 B7.15%
2018A$1.01 B-6.29%
2017A$1.08 B339.49%
2016A$0.24 B-84.76%
2015A$1.62 B153.22%
2014A$0.64 B-54.53%
2013A$1.40 B36.03%
2012A$1.03 B19.93%
2011A$0.86 B38.75%
2010A$0.62 B23.53%
2009A$0.50 B59.64%
2008A$0.31 B54.84%
2007A$0.20 B-23.92%
2006A$0.26 B-7.02%
2005A$0.28 B-38.24%
2004A$0.46 B69.11%
2003A$0.27 B18.76%
2002A$0.23 B-82.03%
2001A$1.29 B

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
A$64.72 B 394.65%๐Ÿ‡บ๐Ÿ‡ธ USA
A$270.75 B 1,969.13%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.235 T 9,344.11%๐Ÿ‡บ๐Ÿ‡ธ USA
A$149.06 B 1,039.16%๐Ÿ‡บ๐Ÿ‡ธ USA
A$595.09 B 4,447.81%๐Ÿ‡บ๐Ÿ‡ธ USA
A$252.09 B 1,826.52%๐Ÿ‡บ๐Ÿ‡ธ USA
A$352.18 B 2,591.48%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$219.05 B 1,574.08%๐Ÿ‡ซ๐Ÿ‡ท France